Protopapas Anna - Insider Non-Derivative Transactions at Mersana Therapeutics, Inc. (MRSN) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jan 16, 2024, Protopapas Anna's relationship to Mersana Therapeutics, Inc. (MRSN) is Director, and currently has 125,153 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other MRSN insiders.

Data Source: SEC.
Protopapas Anna - Insider Non-Derivative Transactions of MRSN Common Stock
Protopapas Anna - Insider Non-Derivative Transactions at MRSN
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jan 17, 2024 Sell -- (Common Stock) 29399 2.71 125153
Jan 16, 2024 M -- (Common Stock) 21250 0 136844
Jan 16, 2024 M -- (Common Stock) 17708 0 154552
Jan 15, 2024 M -- (Common Stock) 16750 0 115594
Jan 14, 2024 M -- (Common Stock) 31250 0 98844
Sep 12, 2023 Acquisition -- (Common Stock) 16643 0 67594
Jan 18, 2023 Sell -- (Common Stock) 17346 5.74 48733
Jan 16, 2023 M -- (Common Stock) 21250 0 48371
Jan 16, 2023 M -- (Common Stock) 17708 0 66079
Jan 15, 2023 M -- (Common Stock) 16750 0 27121
May 21, 2022 G -- (Common Stock) 240244 0 10371
May 21, 2022 G -- (Common Stock) 240244 0 240244